![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ob6112contents.gif)
Acta Cryst. (2002). E58, m83-m85 [ doi:10.1107/S1600536802001678 ]
-N,N'-Bis(salicylidene)-1,3-propanediaminato-N,N'-dimethylformamide]zinc(II)}dichlorozinc(II)Abstract: The title compound, [Zn2Cl2(C17H16N2O2)(C3H7NO)], is a doubly oxygen-bridged dinuclear complex with non-crystallographic mirror symmetry. One of the Zn2+ ions has a distorted square-pyramidal environment involving two O and two N atoms of the bis(salicylidene)-1,3-propanediaminate ligand, and an O atom of dimethylformamide in the axial position. The other Zn2+ ion has a distorted tetrahedral coordination, with average Zn-O and Zn-Cl distances of 1.994 (3) and 2.2108 (14) Å. The Zn
Zn distance is 3.161 (1) Å.
Online 8 February 2002
Copyright © International Union of Crystallography
IUCr Webmaster